 GAVIN
|
Gador
|
| pregabalina |
Antiepiléptico |
| 150 mg cáps.x 28 | $46.668,31 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $23.200,67 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.903,21 AF $18.765,10 |
|
|
|
|
| 150 mg cáps.x 30 | $51.277,53 | (29/03/25) |
| PAMI |
|
| AF $23.772,43 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $27.989,52 AF $23.288,01 |
|
|
|
|
| 25 mg cáps.x 28 | $10.221,16 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $4.533,16 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.206,03 AF $3.015,13 |
|
|
|
|
| 25 mg cáps.x 30 | $10.965,87 | (29/03/25) |
| PAMI |
|
| AF $4.734,40 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $7.262,08 AF $3.703,79 |
|
|
|
|
| 300 mg cáps.x 28 | $64.223,31 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $31.971,72 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $42.426,32 AF $21.796,99 |
|
|
|
|
| 300 mg cáps.x 30 | $66.769,23 | (29/03/25) |
| PAMI |
|
| AF $32.130,15 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $41.488,21 AF $25.281,02 |
|
|
|
|
| 50 mg cáps.x 28 | $20.910,03 | (30/08/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $9.155,08 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $16.192,02 AF $4.718,01 |
|
|
|
|
| 50 mg cáps.x 30 | $23.667,87 | (29/03/25) |
| PAMI |
|
| AF $10.552,61 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.449,24 AF $8.218,63 |
|
|
|
|
| 75 mg cáps.x 28 | $27.048,93 | (16/07/24) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $13.524,47 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $18.452,49 AF $8.596,44 |
|
|
|
|
| 75 mg cáps.x 30 | $30.464,28 | (29/03/25) |
| PAMI |
|
| AF $14.634,19 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.932,47 AF $10.531,81 |
|
|
|
|
| |
